Chemoinformaics analysis of Gallic acid Methyl Ester
| Molecular Weight | 184.147 | nRot | 1 |
| Heavy Atom Molecular Weight | 176.083 | nRig | 7 |
| Exact Molecular Weight | 184.037 | nRing | 1 |
| Solubility: LogS | -1.232 | nHRing | 0 |
| Solubility: LogP | 1.033 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 22.7043 |
| nHD | 3 | BPOL | 10.6297 |
| QED | 0.439 |
| Synth | 2.055 |
| Natural Product Likeliness | 0.711 |
| NR-PPAR-gamma | 0.102 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.025 |
| CACO-2 | -5.036 |
| MDCK | 0.0000113 |
| BBB | 0.154 |
| PPB | 0.853825 |
| VDSS | 0.494 |
| FU | 0.123761 |
| CYP1A2-inh | 0.602 |
| CYP1A2-sub | 0.648 |
| CYP2c19-inh | 0.045 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.233 |
| CYP2c9-sub | 0.437 |
| CYP2d6-inh | 0.07 |
| CYP2d6-sub | 0.222 |
| CYP3a4-inh | 0.109 |
| CYP3a4-sub | 0.107 |
| CL | 16.935 |
| T12 | 0.942 |
| hERG | 0.021 |
| Ames | 0.225 |
| ROA | 0.012 |
| SkinSen | 0.92 |
| Carcinogencity | 0.029 |
| EI | 0.939 |
| Respiratory | 0.145 |
| NR-Aromatase | 0.025 |
| Antiviral | No |
| Prediction | 0.878418 |